Back to companies
PORTFOLIO
Oculis
Oculis focuses on ophthalmic drugs and topical eye drug formulations. Oculis has developed a formulation technology consisting of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug formulation where diseases of the posterior part of the eye can be treated with a simple topical application (i.e., eye drops) instead of injections or implants.
Milestones
Founded: 2017 Invested: 2020
Leadership Team
Riad Sherif
HQ
Lausanne, Switzerland
Earlybird Lead
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.